OK Biotech Co., Ltd. (TPE:4155)
Taiwan · Delayed Price · Currency is TWD 15.15
+0.30 (2.02%)
Sep 18, 2026, 1:30 PM CST
OK Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 370.14 | 314.47 | 277.46 | 323.03 | 596.42 | 599.85 |
Trading Asset Securities | 12.74 | 12.59 | 13.04 | 42.31 | 40.23 | 44.78 |
Cash & Short-Term Investments | 382.88 | 327.06 | 290.5 | 365.34 | 636.64 | 644.64 |
Cash Growth | 115.40% | 12.58% | -20.48% | -42.61% | -1.24% | 13.75% |
Accounts Receivable | 476.48 | 383.12 | 560.19 | 439.36 | 383.27 | 376.79 |
Other Receivables | 6.37 | 26.72 | 28.31 | 49.23 | 26.21 | 28.11 |
Receivables | 482.85 | 409.84 | 588.5 | 488.59 | 409.47 | 404.9 |
Inventory | 445.47 | 456 | 530.54 | 394.05 | 422.95 | 375.64 |
Prepaid Expenses | 53.38 | - | - | 64.47 | 49.47 | 57.76 |
Other Current Assets | 9.54 | 56.36 | 63.13 | 4.91 | 7.98 | 6.06 |
Total Current Assets | 1,374 | 1,249 | 1,473 | 1,317 | 1,527 | 1,489 |
Property, Plant & Equipment | 2,045 | 2,028 | 1,627 | 865.71 | 874.73 | 659.4 |
Long-Term Investments | 24.92 | 23.36 | 22.24 | 358.92 | 458.52 | 482.25 |
Goodwill | 353.52 | 353.52 | 353.52 | 23.63 | 23.63 | 29.63 |
Other Intangible Assets | 105.05 | 111.56 | 124.97 | 1.79 | 8.95 | 16.12 |
Long-Term Deferred Tax Assets | 66.71 | 72 | 62.34 | 57.11 | 51.15 | 44.28 |
Other Long-Term Assets | 24.16 | 11.41 | 32.39 | 442.84 | 117.71 | 92.09 |
Total Assets | 3,994 | 3,849 | 3,695 | 3,067 | 3,061 | 2,813 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 161.82 | 140.42 | 258.32 | 203.8 | 244.63 | 240.4 |
Accrued Expenses | 32.51 | 38.86 | 44.19 | 21.31 | 51.33 | 26.03 |
Short-Term Debt | 195 | 295 | 305 | 155.03 | 185.73 | 187.04 |
Current Portion of Long-Term Debt | 10.1 | 10.19 | 55.46 | 79.62 | 205.64 | 142.8 |
Current Portion of Leases | 19.5 | 10.74 | 3.82 | 3.19 | 3.12 | 2.26 |
Current Income Taxes Payable | 9.89 | 2.24 | 11.87 | - | 33.76 | - |
Current Unearned Revenue | 80.47 | 23.04 | 48.44 | 90.32 | 67.83 | 53.87 |
Other Current Liabilities | 63.27 | 27.13 | 17.67 | 24.86 | 36.14 | 48.16 |
Total Current Liabilities | 572.56 | 547.6 | 744.76 | 578.13 | 828.18 | 700.55 |
Long-Term Debt | 737.16 | 606.46 | 322 | 91.94 | 382.97 | 401.76 |
Long-Term Leases | 82.13 | 90.76 | 33.77 | 2.17 | 3.17 | - |
Long-Term Deferred Tax Liabilities | 24.23 | 25.17 | 27.85 | - | 0.43 | - |
Other Long-Term Liabilities | 3.32 | 3.32 | 0.02 | 0.02 | 0.02 | 7.43 |
Total Liabilities | 1,419 | 1,273 | 1,128 | 672.26 | 1,215 | 1,110 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,447 | 1,448 | 1,471 | 1,458 | 995.02 | 949.34 |
Additional Paid-In Capital | 871.59 | - | - | 922.29 | 600.99 | 562.02 |
Retained Earnings | 323.77 | 263.7 | 247.53 | 158.06 | 268.07 | 203.67 |
Treasury Stock | -59.22 | - | - | - | - | - |
Comprehensive Income & Other | -65.42 | 801.34 | 773.95 | -140.19 | -19.46 | -10.52 |
Total Common Equity | 2,518 | 2,513 | 2,492 | 2,398 | 1,845 | 1,705 |
Minority Interest | 56.76 | 62.93 | 74.84 | -2.76 | 1.79 | -1.5 |
Shareholders' Equity | 2,574 | 2,576 | 2,567 | 2,395 | 1,846 | 1,703 |
Total Liabilities & Equity | 3,994 | 3,849 | 3,695 | 3,067 | 3,061 | 2,813 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,044 | 1,013 | 720.05 | 331.95 | 780.63 | 733.86 |
Net Cash (Debt) | -661.02 | -686.09 | -429.55 | 33.39 | -143.98 | -89.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.53 | -4.70 | -2.93 | 0.26 | -1.11 | -0.75 |
Filing Date Shares Outstanding | 137.17 | 141.12 | 143.06 | 145.77 | 109.66 | 104.63 |
Total Common Shares Outstanding | 137.17 | 141.12 | 143.06 | 145.77 | 109.66 | 104.63 |
Working Capital | 801.56 | 701.65 | 727.9 | 739.22 | 698.33 | 788.44 |
Book Value Per Share | 18.35 | 17.81 | 17.42 | 16.45 | 16.82 | 16.29 |
Tangible Book Value | 2,059 | 2,048 | 2,014 | 2,372 | 1,812 | 1,659 |
Tangible Book Value Per Share | 15.01 | 14.51 | 14.08 | 16.28 | 16.52 | 15.85 |
Land | 417.61 | 417.61 | 417.61 | 417.61 | 417.61 | 185.4 |
Buildings | 345.63 | 345.47 | 345.47 | 345.04 | 344.72 | 343.3 |
Machinery | 330.88 | 342.51 | 321.15 | 320.7 | 286.11 | 190.59 |
Construction In Progress | 1,160 | 1,124 | 791.9 | 20.51 | 16.01 | 93.21 |